FBLN1 and leukemia: We found both Vcam1 and, as previously highlighted, Fn1 and its antagonist Fbln1, to be higher abundant in FLEF relative to BMEF (Fig. 6A), suggesting a stronger impact of VLA-4/Vcam1 and VLA-4/Fn1 interactions in fetal-origin leukemia.